SCHEDULE 13G

Company

Cellectar Biosciences, Inc.

Filed

September 2, 2014

Accession Number

0000929638-14-000729

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →